Viewing Study NCT01199068


Ignite Creation Date: 2025-12-24 @ 5:55 PM
Ignite Modification Date: 2026-01-02 @ 9:44 AM
Study NCT ID: NCT01199068
Status: COMPLETED
Last Update Posted: 2021-05-13
First Post: 2010-08-30
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: CS-7017 in Combination With Erlotinib in Subjects With Stage IIIb/IV Non-small Cell Lung Cancer (NSCLC)
Sponsor: Daiichi Sankyo Co., Ltd.
Organization: